MedPath
NMPA Approval

Regorafenib Tablets

国药准字H20244729

August 27, 2024

Drug Information

瑞戈非尼片

片剂

40mg(按C₂₁H₁₅ClF₄N₄O₃ 计)

化学药品

August 27, 2024

Company Information

Applicant Company

江西省赣州市章贡区青峰大道188号

Manufacturing Company

江西省赣州市章贡区青峰大道188号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

瑞戈非尼片 - NMPA 批准文号 | MedPath